Tags

Type your tag names separated by a space and hit enter

Consideration of the Aerosol Transmission for COVID-19 and Public Health.
Risk Anal. 2020 05; 40(5):902-907.RA

Abstract

This article analyzes the available evidence to address airborne, aerosol transmission of the SARS-CoV-2. We review and present three lines of evidence: case reports of transmission for asymptomatic individuals in association with studies that show that normal breathing and talking produce predominantly small droplets of the size that are subject to aerosol transport; limited empirical data that have recorded aerosolized SARS-CoV-2 particles that remain suspended in the air for hours and are subject to transport over distances including outside of rooms and intrabuilding, and the broader literature that further supports the importance of aerosol transmission of infectious diseases. The weight of the available evidence warrants immediate attention to address the significance of aerosols and implications for public health protection.

Authors+Show Affiliations

Exponent, Inc., Health Sciences, Alexandria, VA.Exponent, Inc., Health Sciences, Alexandria, VA.Exponent, Inc., Health Sciences, Alexandria, VA.Exponent, Inc., Health Sciences, Bowie, MD.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32356927

Citation

Anderson, Elizabeth L., et al. "Consideration of the Aerosol Transmission for COVID-19 and Public Health." Risk Analysis : an Official Publication of the Society for Risk Analysis, vol. 40, no. 5, 2020, pp. 902-907.
Anderson EL, Turnham P, Griffin JR, et al. Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal. 2020;40(5):902-907.
Anderson, E. L., Turnham, P., Griffin, J. R., & Clarke, C. C. (2020). Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Analysis : an Official Publication of the Society for Risk Analysis, 40(5), 902-907. https://doi.org/10.1111/risa.13500
Anderson EL, et al. Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal. 2020;40(5):902-907. PubMed PMID: 32356927.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Consideration of the Aerosol Transmission for COVID-19 and Public Health. AU - Anderson,Elizabeth L, AU - Turnham,Paul, AU - Griffin,John R, AU - Clarke,Chester C, Y1 - 2020/05/01/ PY - 2020/04/20/received PY - 2020/04/20/accepted PY - 2020/5/2/pubmed PY - 2020/5/15/medline PY - 2020/5/2/entrez SP - 902 EP - 907 JF - Risk analysis : an official publication of the Society for Risk Analysis JO - Risk Anal VL - 40 IS - 5 N2 - This article analyzes the available evidence to address airborne, aerosol transmission of the SARS-CoV-2. We review and present three lines of evidence: case reports of transmission for asymptomatic individuals in association with studies that show that normal breathing and talking produce predominantly small droplets of the size that are subject to aerosol transport; limited empirical data that have recorded aerosolized SARS-CoV-2 particles that remain suspended in the air for hours and are subject to transport over distances including outside of rooms and intrabuilding, and the broader literature that further supports the importance of aerosol transmission of infectious diseases. The weight of the available evidence warrants immediate attention to address the significance of aerosols and implications for public health protection. SN - 1539-6924 UR - https://www.unboundmedicine.com/medline/citation/32356927/Consideration_of_the_Aerosol_Transmission_for_COVID_19_and_Public_Health_ L2 - https://doi.org/10.1111/risa.13500 DB - PRIME DP - Unbound Medicine ER -